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Abstract
Purpose :
Retinal ischemia due to diabetic retinopathy or retinal vascular
occlusions is the leading cause of blindness worldwide. Although, the
underlying pathophysiology from each condition is diferent, the
common end results are: inner retinal hypoxia and ischemia. Changes
associated with retinal hypoxia include the simultaneous activation of
diferent pathways including infammatory, aerobic and anaerobic
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metabolic response. Supplementing intravitreal oxygen has been
demonsrated as a novel option in preliminary reports. Our implantable
MEMS oxygenator drivesoxygen from the sub-conjunctival space to the
proximity of the inner retina. The main objective of this sudy is to
determine the efcacy of the oxygenation therapy in an ischemic animal
model.
Methods :
Nine eyes from six pigmented rabbits were included, split
evenly between either healthy, implant-treated or non-treated groups.
Retinal vein occlusion (RVO) was created in all animals from treated
and non-treated groups 3 days prior to surgical implantation and
activation of the oxygenator. Continuous measurements of pO levels
were performed next to the difuser and retinal vessels using an oxygen
probe controlled by a micromanipulator and monitored under indirect
ophthalmoscopy. Eyes were then enucleated and the retina was peeled
of and cryogenically preserved in liquid nitrogen for subsequent
analysis of protein expression.
Results :
RVO was confrmed in all animals immediately after the
procedure and remained occluded over the experiment. Oxygenator
devices were successfully implanted without complications. In the
treated group, oxygen levels increased progressively after a couple of
minutes of activation and remained over 15 mmHg and 100 mmHg
respectively (Figure 1A). For the non-treated group, pO levels did not
increase at the retina or nearby the device (below 5mmHg). Changes
among protein expression and ratio (upregulation on NFkB and PDH;
down-regulation of HIF1a, NFkB/IKKa ratio and P-PDH/PDH ratio) were
observed in the treated group (Figure 1B-C).
Conclusions :
The MEMS oxygenator device can be safely implanted
into the eye. This sudy supports the feasibility of intravitreal oxygen
delivery for treatment of ischemic retinal diseases through infammatory
response modulation. Future experiments will evaluate long-term
efcacy.
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